Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Rockland Immunochemicals acquires eBioscience product line
January 2013
SHARING OPTIONS:

GILBERTSVILLE, Pa.Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development and preclinical studies, announced in mid-December its acquisition of the TrueBlot IP/Western blot product line from eBioscience Inc., an Affymetrix company. TrueBlot reagents enable researchers involved in cancer, cell signaling, infectious disease and other life-science disciplines to generate publication-quality data in immunoprecipitation and Western blot experiments.
 
"The acquisition of the TrueBlot product line expands Rockland's Western blot workflow product offerings and will allow our customers to perform protein research in a more efficient and effective manner, ultimately saving time and precious research dollars," said Rockland President and CEO Jim Fendrick in a press release announcing the acquisition. "The TrueBlot brand has an excellent reputation and is widely considered best-in-class among Western blotting reagents."
 
Rockland will market the TrueBlot IP/Western blot product line on its e-commerce website and through its existing global distribution network.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.